The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 98, Issue 18, 2001, Pages 10386-10391

  Biswas, D K ^a   Dai, S C ^a   Cruz, A ^a   Weiser, B ^a   Graner, E ^a   Pardee, A B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; GO 6796; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR GROWTH; TUMOR NECROSIS;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CARBAZOLES; CELL DIVISION; CYCLIN D1; DNA PRIMERS; ENZYME INHIBITORS; FEMALE; HUMANS; I-KAPPA B KINASE; INDOLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED A; MUTATION; NF-KAPPA B; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ESTROGEN; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0035964203     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.151257998     Document Type: Article

References (41)